A Randomized, Open-label, Three-sequence, Three-period, Three-treatment Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2016
At a glance
- Drugs Adefovir dipivoxil; Clevudine
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Bukwang Pharmaceutical
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2012 Additional lead trial investigator (Kyung-Sang Yoo) identified as reported by ClinicalTrials.gov.